Nivolumab-induced Myositis and Myocarditis with Positive Anti-titin Antibody and Anti-voltage-gated Potassium Channel Kv1.4 Antibody
Author:
Affiliation:
1. Department of Cardiology, Matsudo City General Hospital, Japan
2. Department of Neurology, Matsudo City General Hospital, Japan
3. Department of Medical Oncology, Matsudo City General Hospital, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
https://www.jstage.jst.go.jp/article/internalmedicine/61/19/61_8772-21/_pdf
Reference20 articles.
1. 1. Hottinger AF. Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol 29: 806-812, 2016.
2. 2. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 12: 252-264, 2012.
3. 3. Rota E, Varese P, Agosti S, et al. Concomitant myasthenia gravis, myositis, myocarditis and polyneuropathy, induced by immune-checkpoint inhibitors: a life-threatening continuum of neuromuscular and cardiac toxicity. eNeurologicalSci 14: 4-5, 2019.
4. 4. Yamamoto AM, Gajdos P, Eymard B, et al. Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. Arch Neurol 58: 885-890, 2001.
5. 5. Romi F, Suzuki S, Suzuki N, Petzold A, Plant GT, Gilhus NE. Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis. J Neurol 259: 1312-1316, 2012.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights;Trends in Cancer;2024-08
2. The Current and Future of Biomarkers of Immune Related Adverse Events;Rheumatic Disease Clinics of North America;2024-05
3. Immune Checkpoint Inhibitor Myotoxicities: An Autoimmune Perspective;Internal Medicine;2024
4. Pembrolizumab-induced Myopathy with Anti-striated Muscle Antibodies Successfully Treated by Plasma Exchange;Internal Medicine;2023-12-01
5. Drug therapy for myocarditis induced by immune checkpoint inhibitors;Frontiers in Pharmacology;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3